Navigation Links
ARKRAY USA Receives FDA Clearance on GLUCOCARD(R) 01-mini Blood Glucose Monitoring System
Date:2/9/2009

MINNEAPOLIS, Feb. 9 /PRNewswire/ -- ARKRAY USA, Inc., the 5th largest Blood Glucose Monitoring Company in the world, announced 510(k) clearance from the U.S. Food and Drug Administration for the GLUCOCARD(R) 01-mini Blood Glucose Monitoring System.

This new system requires no coding, displays results in 7 seconds, requires a tiny 0.3 micro liter sample size, and was developed to use the same affordable test strips as the downloadable GLUCOCARD(R) 01 system that launched in 2008. GLUCOCARD(R) 01-mini has AST and features pre/post meal flags. Most notable, the GLUCOCARD(R) 01-mini is the only system on the market that features interchangeable faceplates so users may personalize the look of their monitoring system. It also features an easy-to-read display. The GLUCOCARD(R) 01-mini is distinguished by its leading edge design and technology. Recent clinical data showed GLUCOCARD(R) 01-mini to be highly accurate, precise and easy-to-use.

"ARKRAY is excited to announce a new addition to our growing line of GLUCOCARD(R) blood glucose monitoring systems. The GLUCOCARD(R) 01-mini system follows the GLUCOCARD(R) brand image of sleek, compact, and discreet. The GLUCOCARD(R) 01-mini is unlike other glucose monitors in the market, it features interchangeable face plates," said Jonathan Chapman, President of ARKRAY USA, Inc. "An assortment of faceplates are available, we anticipate making exciting changes to this category by possibly adding a free face plate to each test strip carton and hope to soon make design software available on our website (http://www.glucocardusa.com) so that our customers can make their GLUCOCARD(R) 01-mini as unique as they are."

About ARKRAY USA

ARKRAY has been a pioneer for nearly 50 years in the field of automated analysis from laboratory and point-of-care systems to home use patient self- testing systems. ARKRAY's primary focus throughout that time has been diabetes, developing the world's first hand held blood glucose meter (late 1960s) and the world's first A1C analyzer (1982). ARKRAY is one of the few diabetes testing companies in the US market today that undertakes in-house each step of the development process to bring products to market. ARKRAY is among the leading medical device companies noted for their patent-based intellectual property by Patent Board (Wall Street Journal 11/14/08).


'/>"/>
SOURCE ARKRAY USA, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ARKRAY USA Nationally Launches GLUCOCARD(TM) X-METER Blood Glucose Monitoring System
2. San Diego Medical Community Receives First-Ever Accredited Palliative Medicine Fellowship Program
3. Pulse Systems Receives Dual Certification Under ISO 13485:2003 and ISO 9001:2008
4. Envoii Healthcare License Holder Private Access Inc. Receives TEPR Award
5. Neovasc Receives CE Mark Approval for Peripatch(TM) Aegis Staple Line Reinforcement Product
6. HEALTHeCAREERS Network Receives WEDDLE's 2009 User's Choice Award
7. Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee
8. THE RESULTS ARE IN! VASER(R) Lipo Receives 95% Approval Rating by Physician Users
9. University of Alberta organic chemist receives top young Canadian scientist prize
10. Walden Universitys M.S. in Mental Health Counseling Program Receives CACREP Accreditation
11. Mylan Receives FDA Approval for First-to-File Generic Depakote(R) ER
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... , ... July 21, 2017 , ... ... received a $5,000 grant from the C. R. Bard Foundation, Inc. ... at Somerset Hills , a service available through the nonprofit home care agency. ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the first ... the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related functions ... activity levels decline over time. The study, presented today at the American ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) ... progresses rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a ... relapse. With such a challenging diagnosis that requires immediate action, patients and ...
(Date:7/20/2017)... ... 20, 2017 , ... Team Type 1 Foundation, a nonprofit organization pursuing a ... diabetes, is teaming up with a Microsoft Corp. employee-led hackathon team for the 2017 ... , “Team Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower every ...
(Date:7/20/2017)... ... 2017 , ... The Dermatology Clinic announced today the addition of Dr. Scott ... from LSU, graduating summa cum laude. He attended Emory University School of Medicine in ... Louis, Dr. Dunbar moved to New York to complete an AGCME-accredited Mohs surgery fellowship ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Ill. , July 11, 2017  Sysmex ... and urinalysis diagnostic testing equipment as well as ... innovation: a way to make quality assurance easier ... processes. "Sysmex is well known for the innovation ... Quality Monitor elevates quality assurance processes to ...
(Date:7/11/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... (FDA) has agreed to schedule an End-of-Phase II meeting ... of its oral insulin capsule ORMD-0801 in the treatment ... primary and secondary endpoints by indicating a statistically significant ...
(Date:7/10/2017)... July 10, 2017 The Institute for In ... is the recipient of a VITROCELL® inhalation exposure system ... Science Consortium. The device, which is designed to replace ... human lung cells to airborne test materials in an ... the VITROCELL® system for testing combustible tobacco products, as ...
Breaking Medicine Technology: